Showing results (201-210 of 365) with videos related to

Sort By:
Pageof 37
BMC Cancer|January 19, 2019
Does guideline non-adherence result in worse clinical outcomes for hormone receptor-positive and HER2-negative metastatic breast cancer in premenopausal women?: result of an institution database from South KoreaHee Kyung Kim, Soo-Hyeon Lee, Yu Jin Kim, et al.
Cancers|November 27, 2021
Real-World Data from a Refractory Triple-Negative Breast Cancer Cohort Selected Using a Clinical Data Warehouse ApproachHana Kim, Hyo Jung Kim, Hongsik Kim, et al.
European Journal of Haematology|August 19, 2007
Intestinal marginal zone B-cell lymphoma of MALT type: clinical manifestation and outcome of a rare diseaseSung Yong Oh, Hyuk-Chan Kwon, Won Seog Kim, et al.
Experimental & Molecular Medicine|July 2, 2023
Genomic characteristics of triple negative apocrine carcinoma: a comparison to triple negative breast cancerJi-Yeon Kim, Sabin Park, Eun Yoon Cho, et al.
Therapeutic Advances in Medical Oncology|February 7, 2025
TROPION-Breast04: a randomized phase III study of neoadjuvant datopotamab deruxtecan (Dato-DXd) plus durvalumab followed by adjuvant durvalumab versus standard of care in patients with treatment-naïve early-stage triple negative or HR-low/HER2- breast cancerHeather L McArthur, Sara M Tolaney, Rebecca Dent, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 20, 2014
Prognostic relevance of biological subtype overrides that of TNM staging in breast cancer: discordance between stage and biologyHyun Ae Jung, Yeon Hee Park, Moonjin Kim, et al.
The Lancet. Oncology|May 2, 2024
Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): patient-reported outcomes from a randomised, open-label, multicentre, phase 3 trialTanja Fehm, Francesco Cottone, Kyle Dunton, et al.
Molecular Cancer Research : MCR|June 20, 2020
Clinical Characteristics and Exploratory Genomic Analyses of Germline BRCA1 or BRCA2 Mutations in Breast CancerSehhoon Park, Eunjin Lee, Seri Park, et al.
International Journal of Cancer|December 10, 2008
Treatment outcomes and clinicopathologic characteristics of triple-negative breast cancer patients who received platinum-containing chemotherapyJi Eun Uhm, Yeon Hee Park, Seong Yoon Yi, et al.
Frontiers in Oncology|February 9, 2023
Knowledge, attitudes, and behaviors toward fertility preservation in patients with breast cancer: A cross-sectional survey of physiciansSoo Yeon Baek, Kyung-Hun Lee, Sung-Bae Kim, et al.
Pageof 37